Mangalam Drugs (India) Today
| MANGALAM | 105.92 0.23 0.22% |
Performance0 of 100
| Odds Of DistressLess than 28
|
Mangalam Drugs is trading at 105.92 as of the 17th of January 2025, a 0.22 percent increase since the beginning of the trading day. The stock's open price was 105.69. Mangalam Drugs has about a 28 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 18th of November 2024 and ending today, the 17th of January 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
Mangalam Drugs is entity of India. It is traded as Stock on NSE exchange. The company has 15.83 M outstanding shares. More on Mangalam Drugs And
Moving together with Mangalam Stock
Moving against Mangalam Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Mangalam Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Mangalam Drugs' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Mangalam Drugs or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Chairman MD | Govardhan Dhoot | ||||
| Thematic Idea | Drugs (View all Themes) | ||||
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Drugs, Health Care, Pharmaceuticals, Drug Manufacturers-Specialty & Generic, Healthcare (View all Sectors) | ||||
Mangalam Drugs' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Mangalam Drugs' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsMangalam Drugs can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Mangalam Drugs' financial leverage. It provides some insight into what part of Mangalam Drugs' total assets is financed by creditors.
| |||||
Mangalam Drugs And (MANGALAM) is traded on National Stock Exchange of India in India and employs 432 people. Mangalam Drugs is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.69 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Mangalam Drugs's market, we take the total number of its shares issued and multiply it by Mangalam Drugs's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Mangalam Drugs And operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 15.83 M outstanding shares.
Mangalam Drugs And has accumulated about 917.4 M in cash with 39.13 M of positive cash flow from operations.
Check Mangalam Drugs Probability Of Bankruptcy
Ownership AllocationMangalam Drugs And maintains a total of 15.83 Million outstanding shares. Mangalam Drugs And holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Mangalam Ownership Details
Mangalam Drugs And Risk Profiles
Although Mangalam Drugs' alpha and beta are two of the key measurements used to evaluate Mangalam Drugs' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.69 | |||
| Standard Deviation | 2.78 | |||
| Variance | 7.75 | |||
| Risk Adjusted Performance | (0.05) |
Mangalam Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Mangalam Drugs without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Crypto Correlations Now
Crypto CorrelationsUse cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |
| All Next | Launch Module |
Mangalam Drugs Corporate Management
Elected by the shareholders, the Mangalam Drugs' board of directors comprises two types of representatives: Mangalam Drugs inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Mangalam. The board's role is to monitor Mangalam Drugs' management team and ensure that shareholders' interests are well served. Mangalam Drugs' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Mangalam Drugs' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Krishnapriya Nawal | Chief Officer | Profile | |
| Anuradha Pandey | Company Officer | Profile | |
| Jayant Barde | Company Officer | Profile | |
| Ajay Samant | Chief Officer | Profile |
Other Information on Investing in Mangalam Stock
Mangalam Drugs financial ratios help investors to determine whether Mangalam Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Mangalam with respect to the benefits of owning Mangalam Drugs security.